ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Rheumatology

Top Rheumatology Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KENT PARTAIN MD

Rheumatology

8,600

$969K

596
365 are 65+

19%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$113
Average prescription price

Avg: $140

ERIC GOWING MD

Rheumatology

7,905

$850K

606
370 are 65+

19%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$108
Average prescription price

Avg: $140

JAMES DAVIDSON MD

Rheumatology

6,247

$654K

403
273 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$105
Average prescription price

Avg: $140

RICHARD MISISCHIA D.O.

Rheumatology

5,354

$411K

321
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 23%

$77
Average prescription price

Avg: $140

MARK DAVIS DO

Rheumatology

4,669

$373K

547
388 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$80
Average prescription price

Avg: $140

ANN GIERL DO

Rheumatology

4,667

$480K

394
258 are 65+

17%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$103
Average prescription price

Avg: $140

JOHN FAHEY M.D.

Rheumatology

4,340

$498K

320
236 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$115
Average prescription price

Avg: $140

PAUL UTRIE MD

Rheumatology

4,294

$397K

421
305 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$92
Average prescription price

Avg: $140

ANIL WARRIER M.D.

Rheumatology

4,260

$596K

473
333 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$140
Average prescription price

Avg: $140

DIMITRIOS FANOPOULOS MD MPH

Rheumatology

3,845

$501K

439
296 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$130
Average prescription price

Avg: $140

TOM MURPHY MD

Rheumatology

3,697

$456K

447
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$123
Average prescription price

Avg: $140

DEBORAH WILSON MD

Rheumatology

3,607

$550K

270
196 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$153
Average prescription price

Avg: $140

STEVEN BERGQUIST M.D.

Rheumatology

3,585

$786K

287
214 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$219
Average prescription price

Avg: $140

KURT OELKE M.D.

Rheumatology

3,506

$328K

343
250 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$94
Average prescription price

Avg: $140

DANA TROTTER MD

Rheumatology

3,408

$796K

372
187 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

33%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$234
Average prescription price

Avg: $140

CAROL DANNING MD

Rheumatology

3,387

$407K

361
267 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$120
Average prescription price

Avg: $140

JEANNA OWENS MD

Rheumatology

3,312

$292K

346
274 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$88
Average prescription price

Avg: $140

TIMOTHY SHELLEY MD

Rheumatology

3,302

$489K

362
252 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$148
Average prescription price

Avg: $140

STEVEN KENZER D.O.

Rheumatology

3,196

$424K

359
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$133
Average prescription price

Avg: $140

DANIEL ROSLER M.D.

Rheumatology

3,121

$602K

420
312 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$193
Average prescription price

Avg: $140

THOMAS BARTOW MD

Rheumatology

3,056

$395K

305
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$129
Average prescription price

Avg: $140

SUHAIL HAMEED M.D.

Rheumatology

2,879

$359K

207
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$125
Average prescription price

Avg: $140

PAUL HALVERSON MD

Rheumatology

2,803

$333K

180
88 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$119
Average prescription price

Avg: $140

STEVEN MACIOLEK MD

Rheumatology

2,803

$369K

270
200 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$132
Average prescription price

Avg: $140

HOWARD SWANSON MD

Rheumatology

2,757

$329K

282
206 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$119
Average prescription price

Avg: $140

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank